Bookmark us


Visit of heads of Iranian Hemophilia Society from AryoGen Pharmed Co.

Alborz,Iran- Heads of Iranian Hemophilia Society visited AryoGen pharmed Co. on Thursday 4 th August 2016.
Visiting facility production of AryoGen Pharmed, visitors met the production process of Aryoseven Drug (recombinant factor ᴠІІ) closely, for hours.
Accompanying visitors during the tour, Production Deputy Manager expressed the uniqueness specifications for production of Aryoseven and noted they all strive to produce high quality drug for hemophilia patients. Their continuous efforts, confronting the complications and problems for production process of Aryoseven are all with the aims of improvement of health level of Iranian Society. Confirming the necessity of principled production process, she noted: our attempt is devoted for facile usage and accessibility of this drug for Hemophilia patients; for this purpose, we are planning to produce RT form of this drug.

Satisfied with this visit, Ahmad Ghavidel, Manager of Iranian Hemophilia Society, expressed gratitude for heads of AryoGen Pharmed and noted: we all are proud to have the recombinant factor ᴠІІ (aryoseven) production technology inside and hope to face fewer problems regarding insurance.
More (in Persian)...

During question and answer session, heads of Iranian Hemophilia Society expressed their satisfaction for having production of this drug inside, and expressed their views for easier and better accessibility of patients to Aryoseven. AryoGen Pharmed Co., is unique producer of recombinant factor ᴠІІ in Iran and Middle East. Not only Aryoseven has been marketed domestically, but also it has been exported to several foreign market and is under registration for many others countries as well as EMA ( European Medicine Agency) .